{"article": [{"url": "https://www.marketwatch.com/story/moderna-stock-pops-after-agreeing-to-sell-at-least-100-million-covid-19-vaccine-doses-to-us-government-2020-08-11", "published": 1597169420.0, "headline": "Moderna stock pops after agreement to sell at least 100 million COVID-19 vaccine doses to U.S. government", "body": "Moderna Inc. MRNA, +0.09% announced Tuesday afternoon that it has reached an agreement to sell 100 million doses of its investigational vaccine for COVID-19 to the U.S. government for more than $1.5 billion. \"Breaking: Moderna announces a supply agreement with the U.S. government to secure an initial 100 million doses of mRNA-1273 for up to $1.525 billion with option granted to U.S. government to purchase up to an additional 400 million doses,\" the company revealed in a tweet. Moderna shares jumped more than 8% in after-hours trading immediately following the announcement. Earlier studies of Moderna's vaccine candidate produced antibodies for COVID-19, the company previously announced, and it is currently operating a Phase 3 study of the vaccine. \"The U.S. government has announced that consistent with its commitment to free access to COVID-19 vaccines, Americans will receive mRNA-1273 at no cost for the vaccine itself,\" Moderna added in a subsequent news release. \"As is customary with government-purchased vaccines, healthcare professionals could charge for the cost of administering the vaccine.\" Moderna shares have exploded higher amid the frenzy to develop a COVID-19 vaccine during a worldwide pandemic, with the share price jumping more than 250% so far this year as the S&P 500 index SPX, +0.87% has gained 5.2%."}]}